Issue 4, 1990

Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates: synthesis, antibody linkage, and complexation behaviour

Abstract

A set of four tetra-azamacrocyclic ligands bearing aminomethylphenyl substituents have been prepared and may be attached to a monoclonal antibody via an intermediate thiol-specific vinylpyridine linker molecule. The resultant conjugates may be efficiently radiolabelled with 64Cu or 67Cu at pH 4 to minimise non-specific protein binding, and the copper labelled antibody-conjugate is stable with respect to copper loss in vivo. The forward rate of copper binding has been optimised through a kinetic analysis using stopped-flow spectrophotometry. In succinate buffer, anionic copper species Cu(succ)22–(log β= 4.35) and HCu(succ)2(log β= 9.64) are the kinetically significant copper species in the pH range 3.6–5.6.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 2, 1990, 573-585

Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates: synthesis, antibody linkage, and complexation behaviour

J. R. Morphy, D. Parker, R. Kataky, M. A. W. Eaton, A. T. Millican, R. Alexander, A. Harrison and C. Walker, J. Chem. Soc., Perkin Trans. 2, 1990, 573 DOI: 10.1039/P29900000573

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements